Search

Search bills, members, committees and pages...

ZACHARY FRIEND

37 federal lobbying filings, 2025 to 2026.

ZACHARY FRIEND is a registered lobbyist named on 37 federal lobbying filings, 2025 to 2026, reporting $1.9M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

RegistrantFilingsReported
FEROX STRATEGIES37$1.9M

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202625$1.2M
202512$670K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues29
PHAPharmacy16
TRDTrade (domestic/foreign)15
TAXTaxation/Internal Revenue Code4
CPTCopyright/Patent/Trademark2
FORForeign Relations1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 1071National Defense Authorization Act for Fiscal Year 20263

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
VIATRIS INCFEROX STRATEGIES2026 second_quarter$70KJul 20, 2026
SURGENEXFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
STOKE THERAPEUTICSFEROX STRATEGIES2026 second_quarter$40KJul 20, 2026
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA)FEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
FRESENIUS KABI USA LLCFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
ELI LILLY AND COMPANYFEROX STRATEGIES2026 second_quarter$60KJul 20, 2026
AVIDITY BIOSCIENCES, INC.FEROX STRATEGIES2026 second_quarter$80KJul 20, 2026
ATRIUM THERAPEUTICSFEROX STRATEGIES2026 second_quarter$80KJul 20, 2026
ALEXION PHARMACEUTICALS, INC.FEROX STRATEGIES2026 second_quarter$60KJul 20, 2026
AGE IN PLACEFEROX STRATEGIES2026 second_quarter$20KJul 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
VIATRIS INCFEROX STRATEGIES2026 first_quarter$70KApr 18, 2026
SURGENEXFEROX STRATEGIES2026 first_quarter$50KApr 18, 2026
STOKE THERAPEUTICSFEROX STRATEGIES2026 first_quarter$40KApr 18, 2026
RARE DISEASE COMPANY COALITIONFEROX STRATEGIES2026 first_quarter$50KApr 18, 2026
FRESENIUS KABI USA LLCFEROX STRATEGIES2026 first_quarter$50KApr 17, 2026
ELI LILLY AND COMPANYFEROX STRATEGIES2026 first_quarter$60KApr 17, 2026
AVIDITY BIOSCIENCES, INC.FEROX STRATEGIES2026 first_quarter$80KApr 17, 2026
ATRIUM THERAPEUTICSFEROX STRATEGIES2026 first_quarter$30KApr 17, 2026
ALEXION PHARMACEUTICALS, INC.FEROX STRATEGIES2026 first_quarter$60KApr 17, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 first_quarter$40KApr 17, 2026
AGE IN PLACEFEROX STRATEGIES2026 first_quarterMar 27, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 first_quarterMar 27, 2026
ATRIUM THERAPEUTICSFEROX STRATEGIES2026 first_quarterMar 26, 2026